Viewpoint

Editor's Chair: Fixing European patents

For 30 years, the European Commission has been trying to fix the broken patent process, but keeps running afoul of entrenched intestests. Is it any wonder that European countries keep dropping in the world patent leagues?

German VC - back on track

Friedrich Bornikoel, managing partner for TVM Capital's Information & Communications Technology group, sees a recovery in German venture capital - but still no boom.

Going for growth

Everyone wants to encourage innovation. But, says Alain de Serres from the OECD, a survey of the world’s leading industrial countries shows they are going about it in different ways and with very different results.

A good biotech business…out of Poland?

If you think it’s hard to do a biotech start up, try doing it in Poland. You’ll face international condescension, local incredulity and the mysteries of Polish law, says Charles Goldfinger.

Why big pharma needs little bio

On 26 January, in London, Science|Business organised a roundtable of executives in the biotech industry to discuss the state of the market. The consensus: investor appetite for biotech companies is on the rise.

Biotech: the Greens won't stop it

Marc Van Montagu, Europe's founding father of genetically modified crops and a powerful advocate for their acceptance in Europe, speaks to Science|Business News Editor Thomas Lau.